Cleared Special

K183352 - Optimus Neuro System

K183352 is the FDA 510(k) clearance for Optimus Neuro System by Osteonic Co., Ltd.. It is a Class 2 Neurology device (product code GWO) cleared through the Special 510(k) pathway after a 30-day FDA review.

K183352 · Osteonic Co., Ltd. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2019
Decision
30d
Days
Class 2
Risk

K183352 is an FDA 510(k) clearance for the Optimus Neuro System. Classified as Plate, Cranioplasty, Preformed, Alterable (product code GWO), Class II - Special Controls.

Submitted by Osteonic Co., Ltd. (Seoul, KR). The FDA issued a Cleared decision on January 2, 2019 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5320 - the FDA neurology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Osteonic Co., Ltd. devices

Submission Details

510(k) Number K183352 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 03, 2018
Decision Date January 02, 2019
Days to Decision 30 days
Submission Type Special
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
118d faster than avg
Panel avg: 148d · This submission: 30d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code GWO Plate, Cranioplasty, Preformed, Alterable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Consultant

Bt Solutions, Inc.
Jung Hyeon Park

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - GWO Plate, Cranioplasty, Preformed, Alterable

All 27
Devices cleared under the same product code (GWO) and FDA review panel - the closest regulatory comparables to K183352.
Optimus NEURO System - Sterile Kit
K190811 · Osteonic Co., Ltd. · Nov 2019
Stryker PEEK Customized Cranial Implant Kit
K190229 · Stryker · Jul 2019
Customized Craniofacial Implant (CCI), Customized Skull Implant (CSI)
K182711 · Kelyniam Global, Inc. · May 2019
Universal Mesh - Sterile
K182425 · Stryker Leibinger GmbH & Co KG · Nov 2018
Stryker Universal Mesh
K170725 · Stryker · Nov 2017
Sterile NS System
K170368 · Jeil Medical Corporation · Sep 2017